Navigation

🏠 Home 📰 Latest News 🌍 World 🇮🇳 India 💼 Business 💻 Technology ⚽ Sports 🎬 Entertainment 🏥 Health
Biggest News Aggregation in the World
📰 Clone Pharmaceuticals News

Clone Pharmaceuticals News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Clone Pharmaceuticals. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU(R) (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer

November 9, 2023
ORSERDU is the first treatment specifically approved for patients with ER+, HER2- advanced or metastatic breast cancer tumors that harbor ESR1 mutations, representing the first innovation in endocrine therapy in nearly 20 years.ESR1 mutations are
United States Elcin Barker Ergun Zhao Hong Menarini Group Sciclone Pharmaceuticals Holdings Ltd European Commission
Source: newswit.com

Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer

November 7, 2023
ORSERDU is the first treatment specifically approved for patients with ER+, HER2- advanced or metastatic breast cancer tumors that harbor ESR1 mutations,...
United States Menarini Industrie Farmaceutiche Riunite Elcin Barker Ergun Zhao Hong Sciclone Pharmaceuticals Holdings Ltd Sciclone Pharmaceuticals Holdings Limited
Source: prnewswire.com

Menarini Group and SciClone Pharmaceuticals Announce Exclusive Sub-Licensing Collaboration to Develop and Commercialize ORSERDU® (Elacestrant) in China to Address Advanced or Metastatic Breast Cancer

November 7, 2023
ORSERDU is the first treatment specifically approved for patients with ER+, HER2- advanced or metastatic breast cancer tumors that harbor ESR1 mutations,...
United States Zhao Hong Elcin Barker Ergun Sciclone Pharmaceuticals Holdings Menarini Group European Commission
Source: prnewswire.com

Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem in China to Treat Antimicrobial Resistant Infections

September 20, 2022
Vaborem, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections in China The deal brings together Melinta's innovation, Menarini's cross-regional expertise in registration and marketing this asset, and SciClone's development and commercial presence in China Menarini will receive a total payment of up to 115 million, which includes milestone payments and tiered royalty on net sal...
United States Chong Zhao Christine Ann Miller Maurizio Luongo Menarini Asia Pacific Sciclone Pharmaceuticals Holdings Limited
Source: singaporestar.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science